Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 23589623)

1.

G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis.

Raghuwanshi SK, Smith N, Rivers EJ, Thomas AJ, Sutton N, Hu Y, Mukhopadhyay S, Chen XL, Leung T, Richardson RM.

J Immunol. 2013 May 15;190(10):5329-36. doi: 10.4049/jimmunol.1202058. Epub 2013 Apr 15.

2.

Depletion of beta-arrestin-2 promotes tumor growth and angiogenesis in a murine model of lung cancer.

Raghuwanshi SK, Nasser MW, Chen X, Strieter RM, Richardson RM.

J Immunol. 2008 Apr 15;180(8):5699-706.

3.

The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions.

Raghuwanshi SK, Su Y, Singh V, Haynes K, Richmond A, Richardson RM.

J Immunol. 2012 Sep 15;189(6):2824-32. doi: 10.4049/jimmunol.1201114. Epub 2012 Aug 6.

4.

Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models.

Su Y, Raghuwanshi SK, Yu Y, Nanney LB, Richardson RM, Richmond A.

J Immunol. 2005 Oct 15;175(8):5396-402.

5.

G Protein-coupled receptor kinase-6 interacts with activator of G protein signaling-3 to regulate CXCR2-mediated cellular functions.

Singh V, Raghuwanshi SK, Smith N, Rivers EJ, Richardson RM.

J Immunol. 2014 Mar 1;192(5):2186-94. doi: 10.4049/jimmunol.1301875. Epub 2014 Feb 7.

6.

Growth factor receptor-Src-mediated suppression of GRK6 dysregulates CXCR4 signaling and promotes medulloblastoma migration.

Yuan L, Zhang H, Liu J, Rubin JB, Cho YJ, Shu HK, Schniederjan M, MacDonald TJ.

Mol Cancer. 2013 Mar 5;12:18. doi: 10.1186/1476-4598-12-18.

7.

Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer.

Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ.

Int J Cancer. 2005 Feb 20;113(5):752-60.

PMID:
15499615
8.

Host Cxcr2-dependent regulation of mammary tumor growth and metastasis.

Sharma B, Nannuru KC, Varney ML, Singh RK.

Clin Exp Metastasis. 2015 Jan;32(1):65-72. doi: 10.1007/s10585-014-9691-0. Epub 2014 Dec 16.

PMID:
25511644
9.

Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer.

Yu W, Chen L, Yang YQ, Falck JR, Guo AM, Li Y, Yang J.

Cancer Chemother Pharmacol. 2011 Sep;68(3):619-29. doi: 10.1007/s00280-010-1521-8. Epub 2010 Dec 1.

10.

Increased acute inflammation, leukotriene B4-induced chemotaxis, and signaling in mice deficient for G protein-coupled receptor kinase 6.

Kavelaars A, Vroon A, Raatgever RP, Fong AM, Premont RT, Patel DD, Lefkowitz RJ, Heijnen CJ.

J Immunol. 2003 Dec 1;171(11):6128-34.

11.

Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice.

Fong AM, Premont RT, Richardson RM, Yu YR, Lefkowitz RJ, Patel DD.

Proc Natl Acad Sci U S A. 2002 May 28;99(11):7478-83.

12.

Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor.

Zheng H, Worrall C, Shen H, Issad T, Seregard S, Girnita A, Girnita L.

Proc Natl Acad Sci U S A. 2012 May 1;109(18):7055-60. doi: 10.1073/pnas.1118359109. Epub 2012 Apr 16.

13.

GRK6 deficiency is associated with enhanced CXCR4-mediated neutrophil chemotaxis in vitro and impaired responsiveness to G-CSF in vivo.

Vroon A, Heijnen CJ, Raatgever R, Touw IP, Ploemacher RE, Premont RT, Kavelaars A.

J Leukoc Biol. 2004 Apr;75(4):698-704. Epub 2004 Jan 2.

14.

Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway.

Cai WB, Zhang Y, Cheng R, Wang Z, Fang SH, Xu ZM, Yang X, Yang ZH, Ma JX, Shao CK, Gao GQ.

PLoS One. 2012;7(12):e53152. doi: 10.1371/journal.pone.0053152. Epub 2012 Dec 31.

15.

Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.

Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST.

Clin Cancer Res. 2010 Feb 1;16(3):967-77. doi: 10.1158/1078-0432.CCR-09-1487. Epub 2010 Jan 26.

16.

Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer.

Keane MP, Belperio JA, Xue YY, Burdick MD, Strieter RM.

J Immunol. 2004 Mar 1;172(5):2853-60.

17.

Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis.

Lee YS, Choi I, Ning Y, Kim NY, Khatchadourian V, Yang D, Chung HK, Choi D, LaBonte MJ, Ladner RD, Nagulapalli Venkata KC, Rosenberg DO, Petasis NA, Lenz HJ, Hong YK.

Br J Cancer. 2012 May 22;106(11):1833-41. doi: 10.1038/bjc.2012.177.

18.

Lysophosphatidylcholines activate G2A inducing G(αi)₋₁-/G(αq/)₁₁- Ca²(+) flux, G(βγ)-Hck activation and clathrin/β-arrestin-1/GRK6 recruitment in PMNs.

Khan SY, McLaughlin NJ, Kelher MR, Eckels P, Gamboni-Robertson F, Banerjee A, Silliman CC.

Biochem J. 2010 Nov 15;432(1):35-45. doi: 10.1042/BJ20091087.

19.

22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer.

Nakagawa K, Sasaki Y, Kato S, Kubodera N, Okano T.

Carcinogenesis. 2005 Jun;26(6):1044-54. Epub 2005 Feb 17.

20.

CXCR2 promotes ovarian cancer growth through dysregulated cell cycle, diminished apoptosis, and enhanced angiogenesis.

Yang G, Rosen DG, Liu G, Yang F, Guo X, Xiao X, Xue F, Mercado-Uribe I, Huang J, Lin SH, Mills GB, Liu J.

Clin Cancer Res. 2010 Aug 1;16(15):3875-86. doi: 10.1158/1078-0432.CCR-10-0483. Epub 2010 May 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk